Correlation - European Harm Reduction Network
Correlation - European Harm Reduction Network (C-EHRN) is a European civil society network and centre of expertise uniting 100+ harm reduction organisations across 30+ countries, delivering monitoring data, capacity-building resources, and advocacy for evidence-based drug policy.
- Company typePrivate
- Founded2004
- HeadquartersAmsterdam, Noord-Holland, Netherlands
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Correlation - European Harm Reduction Network does
Correlation - European Harm Reduction Network (C-EHRN) is a European civil society network and centre of expertise established in 2004 in Amsterdam, hosted by Foundation De Regenboog Groep (FRG). It unites community-based organisations, research institutes, health providers, and policymakers across more than 30 countries in the WHO Europe Region, reaching beneficiaries including people who use drugs, people experiencing homelessness, people living with HIV/HCV, people in prison, migrants, sex workers, women, and youth. The network's primary operational artefacts are the C-EHRN Monitoring Dashboard (annual city-level data on harm reduction service availability, accessibility, quality, equity, and human rights), the Learn Addiction e-learning platform, the Behind the Walls prison harm reduction toolkit, and the ENDCR European Network of Drug Consumption Rooms. C-EHRN also convenes the biennial European Harm Reduction Conference and maintains formal participation in EU civil society forums on drugs and on HIV/AIDS, viral hepatitis, and tuberculosis.
C-EHRN operates as a grant-funded non-governmental network rather than a technology product company; its principal offerings are data, publications, capacity-building resources, and advocacy infrastructure. Underlying assets include the Focal Point monitoring network (40+ reference organisations across Europe), the membership base (100+ organisations), and curated datasets on harm reduction services collected annually since 2018 that complement official EU monitoring. Distribution is non-commercial: publications, toolkits, and reports are published openly on correlation-net.org, while field-level implementation is carried out by member organisations and Focal Points.
The business model is project-based grant funding. Revenue streams include EU grants channelled through programmes such as EU4Health, Erasmus+, HaDEA, the EUDA (successor to EMCDDA), and the EU Justice Programme, plus philanthropic grant support from Gilead Sciences Europe Ltd. A small secretariat of approximately 13 staff in Amsterdam coordinates the network under director Katrin Schiffer; an Advisory Committee elected by members, a Scientific Advisory Board, and Expert Networks provide governance. C-EHRN does not sell products or services and has no pricing structure; sustainability is contingent on continued public-sector and philanthropic funding for harm reduction, drug policy, and public health priorities.
Correlation - European Harm Reduction Network firmographics
Firmographics- Name
- Correlation - European Harm Reduction Network
- Legal name
- Correlation – European Harm Reduction Network
- Website
- https://correlation-net.org
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Correlation - European Harm Reduction Network (C-EHRN) is a European civil society network and centre of expertise uniting 100+ harm reduction organisations across 30+ countries, delivering monitoring data, capacity-building resources, and advocacy for evidence-based drug policy.
- Ownership category
- akta.pro rank
Correlation - European Harm Reduction Network industry classification
Industry- Product category
- Harm Reduction Services / Civil Society Network
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Social Services (8300), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)
- akta.pro secondary industries
- Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships (HLAJAOAL), Non-Communicable Disease Prevention & Chronic Disease Programs (BPAIAJAI)
Keywords
Where Correlation - European Harm Reduction Network is headquartered
LocationHeadquarters
- HQ city
- Amsterdam, Noord-Holland
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Correlation - European Harm Reduction Network business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- European Union Funding: C-EHRN is co-funded by the European Union, receiving grants for its network operations and thematic projects (EU4Health, Erasmus+, HaDEA, EUDA, Justice Programme). Projects include C-EHRN Monitoring, ENDCR, EU-COMP, CAPABLE, BOOST, CORE, DRUG-PREP, SO-PREP, SEMID-EU, FENIQS-EU, Learn Addiction, and others.
- Philanthropic Funding: C-EHRN acknowledges financial grant support from Gilead Sciences Europe Ltd. for specific project activities.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels10 records
Correlation - European Harm Reduction Network product offering
Product offeringCore offering
Correlation – European Harm Reduction Network (C-EHRN) is a civil society network and centre of expertise that unites harm reduction organisations, researchers and policymakers across the WHO Europe Region to advance evidence-based drug policy and practice. It delivers annual city-level monitoring data on harm reduction services, capacity-building tools, e-learning, advocacy kits, and a biennial European Harm Reduction Conference. Resources are distributed free of charge to member organisations and the broader harm reduction community.
Product overview
Correlation - European Harm Reduction Network (C-EHRN) is a civil society network organization rather than a traditional product company. Its primary offerings include the C-EHRN Monitoring Dashboard for tracking harm reduction services across European cities, the Learn Addiction E-Learning Platform for professional development in substance use fields, and various toolkits including the Behind the Walls prison harm reduction toolkit. The network also publishes annual monitoring reports, thematic publications, and provides resources through its member organizations across Europe.
Differentiator
Problem solved
Functional benefit
Brands
- C-EHRN Monitoring: Annual civil society-led monitoring of harm reduction services across Europe, providing city-level data on service availability and gaps
- ENDCR - European Network of Drug Consumption Rooms
- European Hepatitis C Initiative
Quantifiable outcome
- Annual monitoring reports published since 2018 covering harm reduction service availability, accessibility, quality, equity, and human rights across 30+ European cities.
- +2 more outcomes
Companies that use Correlation - European Harm Reduction Network
Customer profileNamed customers17 records
Segments8 records
Ideal customer profiles2 records
Correlation - European Harm Reduction Network technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Correlation - European Harm Reduction Network partnerships and signals
Strategic signalPartnerships
24 partnerships are on record, tiered core and major.
- OKANA (Greece)corePartner in ENDCR technical meetings on drug consumption rooms, co-organised with OKANA and EMCDDA/EUDA in Athens in June 2024.
- European Forum for Urban Security (EFUS)majorC-EHRN partners with EFUS as coordinator of the CAPABLE project on strengthening local responses to youth involvement in drug markets.
- International Network of People Who Use Drugs (INPUD)coreCollaborates on peer involvement projects, monitoring activities, and advocacy for meaningful involvement of people who use drugs in policy.
- Drug Policy Network South East Europe (DPNSEE)majorPartner in BOOST and civil society monitoring projects, contributing to drug policy advocacy in Southeast Europe.
- European Harm Reduction International (EHRI)majorCollaborates with EHRI on harm reduction advocacy, monitoring, and international knowledge exchange.
- SCAN / Charles UniversitycorePartner in the EU-COMP project for developing harmonised training frameworks for the EU addiction workforce.
- European Federation of Addiction Societies (EUFAS)corePartner in EU-COMP, contributing to competence-building materials and professional development for the substance use workforce in Europe.
- European Network of People Who Use Drugs (EuroNPUD)corePartner in EU-COMP, ensuring meaningful involvement of people who use drugs in curriculum development and workforce training.
- European Union Drugs Agency (EUDA)coreEUDA funds and partners on EU-COMP and co-organises technical meetings on drug consumption rooms with ENDCR/C-EHRN. EUDA is the successor to the EMCDDA.
- CAPABLE Partners (EFUS, GI-TOC, Ghent University, Genk, Rotterdam, Lisbon, Cali)majorErasmus+ project on youth involvement in drug markets, bringing together harm reduction, youth, prevention services, and police stakeholders. C-EHRN partners with EFUS (coordinator), GI-TOC, and Ghent University.
- CORE Project Partners (24 partners, 16 EU Member States)majorEU4Health-funded project (January 2023 – December 2025) involving 24 partners across 16 EU Member States, aimed at reducing inequalities in HIV, TB, and viral hepatitis responses by promoting community responses.
- BOOST Project PartnersmajorEU4Health-funded project coordinated by C-EHRN, involving partners such as ABD, DPNSEE, Fondazione Villa Maraini, EHRA, EuroNPUD, IGTP, ISGlobal. Aims to enhance community-based HIV, HCV, and STI services.
- SEMID-EU Partners (Mainline, Gaia Paris, Fixpunkt, ISGlobal, Positive Voice, Ghent University)majorEU Justice Programme-funded project addressing migration and drug use in the EU, led by Mainline. C-EHRN collaborates with Gaia Paris, Fixpunkt, ISGlobal, Positive Voice, and Ghent University.
- European AIDS Treatment Group (EATG)corePartner in CORE project and civil society forums on HIV, hepatitis, and TB. Collaborates on policy dialogue and community response to health inequalities.
- Eurasian Harm Reduction Association (EHRA)corePartner in BOOST and other projects, contributing to harm reduction advocacy and capacity building across Europe.
- FEANTSA (European Federation of National Organisations Working with the Homeless)majorPartner in HR4Homelessness project and HR4Homelessness Resource Hub and Good Practice Collection, promoting harm reduction in homeless services.
- Trans European Drug Information Network (TEDI)coreTEDI contributes to drug checking trends monitoring, with C-EHRN-TEDI Monitoring reports published on European Drug Checking Trends.
- Global Initiative against Transnational Organised Crime (GI-TOC)majorPartner in CAPABLE project, contributing expertise on organised crime and drug market responses.
- Nobody Left Outside (NLO) InitiativemajorCollective of organisations representing marginalised communities (homeless, LGTBI, people who use drugs, prisoners, sex workers, migrants) working to improve healthcare access. C-EHRN is a participant.
- FENIQS-EU Partners (Ghent University, University of Zagreb, Claude Bernard University of Lyon, IREFREA, EUFAS, Euro-TC)majorProject on implementing Quality Standards in drug demand reduction throughout the EU, led by University of Gent. C-EHRN contributed to identifying good practice examples and developing implementation toolkits.
- Gent UniversitycoreAcademic partner in the C-EHRN Monitoring (since 2018) and EU-COMP project. Contributes scientific expertise to monitoring activities and curriculum development for the addiction workforce.
- European Commission - Civil Society Forum on DrugscoreC-EHRN participates in the Civil Society Forum on Drugs, an expert group of the European Commission established in 2007 to facilitate NGO participation in drug policy development.
- EU HIV/AIDS, Viral Hepatitis and Tuberculosis Civil Society ForumcoreC-EHRN participates in this forum established by the European Commission, extended in 2017 to include viral hepatitis and TB organisations.
- Foundation De Regenboog Groep (FRG)coreC-EHRN is hosted by FRG in Amsterdam. FRG is a non-governmental low-threshold service organisation providing harm reduction services to people who use drugs. The C-EHRN director also serves as Head of FRG's International Department.
Scale indicators5 records
Recent moves7 records
Expansion highlights7 records
Correlation - European Harm Reduction Network competitors and assessment
Company assessmentBroad incumbents
- Drug Policy Alliance: US-based drug policy reform organisation with global advocacy reach. Comparable mission and advocacy orientation to C-EHRN but operates at significantly larger scale, is US-centric rather than Europe-focused, and combines advocacy with sizeable grant-making activity.
Direct peers
- Harm Reduction International: Global civil society organisation dedicated to reducing drug-related harms. Closest peer to C-EHRN in mission, advocacy orientation, and convening role; operates at global level rather than Europe-only and does not run the same civil-society-led city monitoring programme.
- Eurasian Harm Reduction Association (EHRA): Regional harm reduction network covering Eastern Europe and Central Asia, with overlapping membership, partner organisations, and EU-funded project collaborations with C-EHRN (e.g., BOOST). Directly comparable in scope, governance, and donor base, but with a different geographic remit.
- International Network of People Who Use Drugs (INPUD): Global peer-run network advocating for the rights and health of people who use drugs. C-EHRN collaborates with INPUD on peer involvement projects and monitoring; both share a civil-society, advocacy-led operating model at the intersection of drug policy and human rights.
- European AIDS Treatment Group (EATG): European civil society organisation of people living with HIV/AIDS and their advocates. C-EHRN is a partner in the CORE project and the EU HIV/AIDS, Viral Hepatitis and TB Civil Society Forum; comparable in being a pan-European membership-based health advocacy network.
- European Network of People Who Use Drugs (EuroNPUD): European regional peer network of people who use drugs, listed as a partner in C-EHRN's EU-COMP project. Operates a comparable membership and advocacy model focused on meaningful involvement of drug users in European drug policy.
- Release (UK): UK-based drugs charity providing advice, advocacy, and harm reduction services, listed as a C-EHRN member organisation. Comparable in mission and harm-reduction service orientation, though UK-focused rather than pan-European.
- Drug Policy Network South East Europe (DPNSEE): Regional civil society network coordinating drug policy and harm reduction advocacy across South East Europe. Listed as a C-EHRN project partner (BOOST, monitoring), with comparable membership-based structure and policy-focused activities.
Emerging players
- European Public Health Alliance (EPHA): European civil society alliance working on public health policy across multiple verticals including harm reduction, infectious disease, and health systems. Comparable in EU-policy advocacy model but covers a broader health portfolio rather than specialising in harm reduction.
Others
- European Union Drugs Agency (EUDA): EU agency (formerly EMCDDA) that funds C-EHRN projects and co-produces technical outputs. Not a civil society peer but a key funder and counterpart; relevant for benchmarking C-EHRN's monitoring and policy work against the EU's official drug data infrastructure.
Market position
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Correlation - European Harm Reduction Network social profiles
Digital presenceCorrelation - European Harm Reduction Network financial estimates
Financial estimateRevenue estimate
Valuation estimate
Correlation - European Harm Reduction Network leadership team
Management profileNumber of profiles
Profiles12 records
Correlation - European Harm Reduction Network funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Correlation - European Harm Reduction Network M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Correlation - European Harm Reduction Network
What does Correlation - European Harm Reduction Network do?
Correlation – European Harm Reduction Network (C-EHRN) is a civil society network and centre of expertise that unites harm reduction organisations, researchers and policymakers across the WHO Europe Region to advance evidence-based drug policy and practice. It delivers annual city-level monitoring data on harm reduction services, capacity-building tools, e-learning, advocacy kits, and a biennial European Harm Reduction Conference. Resources are distributed free of charge to member organisations and the broader harm reduction community.
Is Correlation - European Harm Reduction Network a public or private company?
Correlation - European Harm Reduction Network is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Correlation - European Harm Reduction Network founded?
Correlation - European Harm Reduction Network was founded in 2004. It employs 11 to 50 people.
Where is Correlation - European Harm Reduction Network based?
Correlation - European Harm Reduction Network is headquartered in Amsterdam, Noord-Holland, Netherlands, in the Europe region.
How does Correlation - European Harm Reduction Network make money?
Two revenue lines are on record. European Union Funding is the primary driver. The others are philanthropic Funding.
Who are Correlation - European Harm Reduction Network's main competitors?
Drug Policy Alliance is listed as a broad incumbent. Direct peers are Harm Reduction International, Eurasian Harm Reduction Association (EHRA), International Network of People Who Use Drugs (INPUD), European AIDS Treatment Group (EATG), European Network of People Who Use Drugs (EuroNPUD), Release (UK) and Drug Policy Network South East Europe (DPNSEE). European Public Health Alliance (EPHA) is listed as an emerging player. European Union Drugs Agency (EUDA) is listed as an others.
Does Correlation - European Harm Reduction Network have an API?
No public API is recorded for Correlation - European Harm Reduction Network.
What industry is Correlation - European Harm Reduction Network in?
Correlation - European Harm Reduction Network's product category is Harm Reduction Services / Civil Society Network. Its primary akta.pro industry code is HLAJAOAM, Global Health Research, Clinical Trials & Product Development Partnerships (PDPs), with a secondary code of HLAJAOAL, Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships. Its NAICS code is 5417 and its SIC code is 8300.